-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DGlP++WTshIfRdAx4y4h4FKVuDTbfzY6Ul2TOHoKCjME+IoAZ5AfZqCYLxi100ec oUtZPe61G57l+dlGGKAxdw== 0001192128-08-000006.txt : 20081017 0001192128-08-000006.hdr.sgml : 20081017 20081017160006 ACCESSION NUMBER: 0001192128-08-000006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20081015 FILED AS OF DATE: 20081017 DATE AS OF CHANGE: 20081017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: (908) 450-5300 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nader Francois CENTRAL INDEX KEY: 0001365343 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 081129524 BUSINESS ADDRESS: BUSINESS PHONE: 801-583-4939 MAIL ADDRESS: STREET 1: 383 COLOROW DRIVE CITY: SALT LAKE CITY STATE: X1 ZIP: 84108 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2008-10-15 0000890465 NPS PHARMACEUTICALS INC NPSP 0001365343 Nader Francois 550 HILLS DRIVE BEDMINSTER NJ 07921 0 1 0 0 President & CEO Stock Option 5.85 2008-10-15 4 W 0 18750 0 A 2009-10-15 2018-10-15 Common Stock 18750 18750 D Stock options granted under the 1998 Stock Option Plan. The options become exercisable based on the following four-year vesting schedule: 28% on the first anniversary of the grant and 2% each month thereafter. Andrew Rackear 2008-10-15 -----END PRIVACY-ENHANCED MESSAGE-----